Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 14/20 | 0.56 |
| ▸ | NPY1R | P25929 | 9/20 | 0.56 |
| ▸ | NPY5R | Q15761 | 8/20 | 0.56 |
| ▸ | NPY2R | P49146 | 5/20 | 0.56 |
| ▸ | FNTA | P49354 | 3/20 | 0.52 |
| ▸ | FNTB | P49356 | 3/20 | 0.52 |
| ▸ | PGGT1B | P53609 | 3/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1940080 | 1.00 | NPY4R (0.56) | NPY4RNPY1RNPY5RNPY2RFNTA | |
| SCHEMBL1727152 | 1.00 | NPY4R (0.56) | NPY4RNPY1RNPY5RNPY2RFNTA | |
| Acetic Acid SCHEMBL230815 | 0.98 | NPY4R (0.55) | NPY4RNPY1RNPY5RNPY2RFNTA | |
| Acetic Acid SCHEMBL8587360 | 0.98 | NPY4R (0.55) | NPY4RNPY1RNPY5RNPY2RFNTA | |
| Acetic Acid SCHEMBL230814 | 0.98 | NPY4R (0.55) | NPY4RNPY1RNPY5RNPY2RFNTA | |
| Acetic Acid SCHEMBL2341079 | 0.97 | NPY4R (0.54) | NPY4RNPY1RNPY5RNPY2RFNTA | |
| Acetic Acid SCHEMBL2341088 | 0.97 | NPY4R (0.54) | NPY4RNPY1RNPY5RNPY2RFNTA | |
| SCHEMBL30866932 | 0.95 | NPY4R (0.55) | NPY4RNPY1RNPY5RNPY2RFNTA | |
| SCHEMBL29619346 | 0.93 | FNTA (0.60) | NPY4RNPY1RNPY5RNPY2RFNTA | |
| SCHEMBL29352845 | 0.93 | FNTA (0.58) | NPY4RNPY1RNPY5RNPY2RFNTA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120148576-A1 | HUMANIZED ANTI-CD 19 ANTIBODY FORMULATIONS | MEDLMMUNE, LLC (US) | 2012-06-14 | — | — | US | disclosed |
| EP-2403532-A2 | HUMANIZED ANTI-CD19 ANTIBODY FORMULATIONS | MedImmune, LLC (US) | 2012-01-11 | — | — | EP | disclosed |
| WO-2010102276-A2 | HUMANIZED ANTI-CD19 ANTIBODY FORMULATIONS | MEDIMMUNE, LLC (US) | 2010-09-10 | — | — | WO | disclosed |